What caused the SOON.SW stock drop today?

SOON.SW stock fell **4.03%** on 24 Mar 2026 on above-average volume. The move reflects continued sector pressure, multiple compression, and technical selling after a multi-month decline rather than a single company-only headline.

Is SOON.SW stock a buy at CHF171.30?

Meyka AI assigns SOON.SW a **B+ (Buy)** grade with a 12‑month model target of **CHF207.07**. That implies ~**20.90%** upside, but risks and short-term downside remain. Consider earnings on 18 May 2026 and your risk profile before buying.

What are the main risks for SOON.SW investors?

Key risks include slower hearing-device demand, margin erosion, high intangibles, and short-term momentum selling. Financial metrics show moderate leverage (debt/equity **0.76**), so shocks could hurt earnings if growth slows.

When is Sonova’s next earnings report and why it matters for SOON.SW stock?

Sonova’s next earnings announcement is scheduled for **18 May 2026**. The report matters because guidance on revenue and margins could shift sentiment and validate or contradict Meyka’s 12-month forecast of **CHF207.07**.

CH Stocks

Sonova SOON.SW drops 4.03% to CHF171.30 on 24 Mar 2026: market closed, outlook

ByDanny Kontos March 24, 2026March 24, 2026

The SOON.SW stock closed the SIX session down 4.03%, falling to CHF171.30 on 24 Mar 2026 as volume spiked to 214,893.00 shares. Investors pushed the medical device leader lower after a sustained multi-month slide; today’s move left Sonova Holding AG (SOON.SW) trading well below its 50-day average of CHF202.90 and 200-day average of CHF217.58. We examine valuation, technical signals, Meyka grade and the forecasts that frame whether this decline is a buying window or a warning for Switzerland-listed shareholders.